PRVL insider transactions
Prevail Therapeutics Inc. (PRVL) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.
Recent Form 3, 4, and 5 filings for PRVL
- SEC Form 4 filed by Llc Advisors Orbimed4 - Prevail Therapeutics Inc. (0001714798) (Issuer)
- SEC Form 4: Asa Abeliovich decreased ownership by 100% to 0 units4 - Prevail Therapeutics Inc. (0001714798) (Issuer)
- SEC Form 4 filed by M Timothy Adams4 - Prevail Therapeutics Inc. (0001714798) (Issuer)
- SEC Form 4 filed by H. William Carson4 - Prevail Therapeutics Inc. (0001714798) (Issuer)
- SEC Form 4 filed by Yong Dai4 - Prevail Therapeutics Inc. (0001714798) (Issuer)
- SEC Form 4 filed by Franz Hefti4 - Prevail Therapeutics Inc. (0001714798) (Issuer)
- SEC Form 4 filed by Brett Kaplan4 - Prevail Therapeutics Inc. (0001714798) (Issuer)
- SEC Form 4: Emily Minkow decreased ownership by 100% to 0 units4 - Prevail Therapeutics Inc. (0001714798) (Issuer)
- SEC Form 4 filed by Francois Nader4 - Prevail Therapeutics Inc. (0001714798) (Issuer)
- SEC Form 4 filed by M. Kira Schwartz4 - Prevail Therapeutics Inc. (0001714798) (Issuer)
- SEC Form 4 filed by Jeffrey Sevigny4 - Prevail Therapeutics Inc. (0001714798) (Issuer)
- SEC Form 4 filed by Morgan Sheng4 - Prevail Therapeutics Inc. (0001714798) (Issuer)
- SEC Form 4 filed by Ran Nussbaum4 - Prevail Therapeutics Inc. (0001714798) (Issuer)
- SEC Form 4 filed by L Carl Gordon4 - Prevail Therapeutics Inc. (0001714798) (Issuer)
- SEC Form 4 filed by A. Peter Thompson4 - Prevail Therapeutics Inc. (0001714798) (Issuer)
- SEC Form 4: Corp Acquisition Tyto bought $771,407,752 worth of Common Stock (34,284,789 units at $22.50)4 - Prevail Therapeutics Inc. (0001714798) (Issuer)